Advancements in Stroke Treatment and the CONVINCE Trial

Exploring the differentiation of stroke types and the potential use of colchicine as an anti-inflammatory treatment in non-cardiogenic strokes as discussed in the CONVINCE trial, sparking debate on integrating anti-inflammatory strategies into stroke prevention protocols.